In a sign of things to come, medical-device maker Medtronic PLC has entered into a deal to operate the heart-catheterization and electrophysiology labs at a large academic medical center in Cleveland.
Cath labs and EP labs are specialty centers inside larger hospitals where the kinds of cardiovascular products Medtronic sells are often used, including higher-margin stents and foldable aortic heart valves, and a wide array of lower-tech hospital supplies.
"The benefits remain to be seen, but we believe them to be an improvement in efficiency, labor management, supply chain management, [patient] throughput, scheduling — all the operating functions of the clinical unit," said Dr. Jeffrey Peters, chief operating officer of University Hospitals Cleveland Medical Center, which announced a partnership with Medtronic on Tuesday. A spokeswoman said the hospital has 1,032 beds.
Peters said as many as 10 Medtronic employees will work at UH Cleveland Medical Center, performing nonclinical work. They will not be involved in making decisions on medical cases.
Asked whether the hospital considers the arrangement to be an outsourcing of its lab operations, Peters said, "We consider it a partnership."
More such "integrated health solutions" deals from Medtronic are expected in the U.S.
Medtronic, which is run from Minnesota and legally domiciled in Ireland, already has arrangements to operate more than 100 cath labs and operating rooms in hospitals around Europe and other regions of the globe.
Tuesday's announcement with the Cleveland hospital signals that Medtronic is ready to bring such arrangements to the U.S.